Effectiveness of SMS Reminders of Blood Pressure-lowering Drugs Intake

NCT03105687 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2018-02-19

No results posted yet for this study

Summary

By conducting the SPPA trial we try to find out, whether personalized Short Message Service (SMS) reminders of blood pressure-lowering medication can effectively increase patients' adherence to blood pressure-lowering medication. Additionally, we also evaluate their effect on patients' systolic blood pressure control.

Conditions

  • Hypertension
  • Primary Hypertension
  • Non-Adherence, Medication
  • Non-Adherence, Patient

Interventions

BEHAVIORAL

SMS reminders of medicines intake

The intervention consists of daily SMS reminders of blood pressure-lowering medication provided by a pharmacist for a period of 3 months.

Sponsors & Collaborators

  • University of California, Los Angeles

    collaborator OTHER
  • Research Institute for Child Psychology and Pathopsychology

    collaborator UNKNOWN
  • Dr. Max Pharmacies

    collaborator UNKNOWN
  • Comenius University

    lead OTHER

Principal Investigators

  • Zuzana Haramiova, PharmDr. · Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy

  • Magdalena Kuzelova, Prof., PharmDr., PhD. · Faculty of Pharmacy Comenius University in Bratislava, Department of Pharmacology and Toxicology

  • Donald M. Morisky, Sc.D., M.S.P.H., Sc.M. · Fielding School of Public Health, Department of Community Health Sciences

  • Tomas Tesar, Doc., PharmDr., PhD, MBA · Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy

  • Michal Stasko, PharmDr. · Faculty of Pharmacy Comenius University in Bratislava, Department of Organization and Management of Pharmacy

  • Martin Hulin, Ing., Mgr., PhD. · Research Institute for Child Psychology and Pathopsychology

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-16
Primary Completion
2018-01-10
Completion
2018-02-14

Countries

  • Slovakia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03105687 on ClinicalTrials.gov